Olmesartan Medoxomil: As Monotherapy and in Combination Treatment in Hypertension

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.17, Iss.1, 2010-03, pp. : 1-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Strategies and Drugs in the Treatment of Hypertension: Monotherapy or Combination?

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 69-81

Bentham Science Publishers

Access to resources Recommend Favorite

Olmesartan for the treatment of arterial hypertension

By Schindler Christoph Ferrario Carlos M

Future Cardiology, Vol. 4, Iss. 4, 2008-07 ,pp. : 357-372

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetics and Safety of Olmesartan Medoxomil in Combination with Glibenclamide in Healthy Volunteers

By Huber Matthias Bolbrinker Juliane Kreutz Reinhold

Clinical and Experimental Hypertension, Vol. 28, Iss. 7, 2006-10 ,pp. : 631-643

Informa Healthcare

Access to resources Recommend Favorite

Drug review - Olmesartan medoxomil

By Clark Richard

Drugs In Context Primary Care Part B: Cardiovascular Medicine II, Vol. 1, Iss. 8, 2004-09 ,pp. : 309-322

CSF Medical Communications Ltd

Access to resources Recommend Favorite

Olmesartan Medoxomil Treatment Is Associated with Decreased Plasma B-Type Natriuretic Peptide Levels in Patients on Hemodialysis

By Suzuki Ryuji Honda Hirokazu Niikura Kazuhiko Akizawa Tadao

Clinical and Experimental Hypertension, Vol. 34, Iss. 2, 2012-04 ,pp. : 125-131

Informa Healthcare

Access to resources Recommend Favorite